A recent study from Cleveland suggests that people who have previous COVID-19 infection history may not gain any benefit from getting the vaccines.
Scientists from the Cleveland Clinic, USA, conducted their study on observing over 52,000 employees at their clinic and published their findings on June 5 via medRxiv.
The researchers looked at the nuances of vaccine effectiveness on three groups, those who were previously infected, those with a clear CCP Virus history who were already vaccinated, and those who were infected and inoculated subsequently.
Comparing the data, scientists found that immunizations greatly reduced the chance of CCP Virus infection in people who had never tested positive for the virus, but not in people who had previously been infected.
Among the participants who caught the virus, 99.3% of them has either been infected before or took the vaccines against the disease. Chance of vaccination breakthrough was also there, but not significant, with 0.7% of the infected cases were vaccinated individuals who had never had any experience with the virus.
From the proportion they were able to draw out, researchers of the study added that those who have previously been infected with the CCP Virus obtain no further benefits from vaccination, but those who have not been infected with the lethal virus obtain the most advantage.
It is worth mentioning that all respondents who had previously been infected with COVID-19 were not sickened by the virus again. This would be a positive indication for those who had survived the airborne illness.
This result, of course, did not escape catching Sen. Rand Paul’s attention, who not long ago bluntly stated that he would decline the COVID-19 vaccine because he already had a natural immune mechanism thanks to his 2020 infection experience.
“Great news! Cleveland clinic study of 52,238 employees shows unvaccinated people who have had COVID 19 have no difference in re-infection rate than people who had COVID 19 and who took the vaccine,” he wrote on Twitter.
“This information frees up millions of doses of vaccines for those not yet infected in places with vaccine shortages like India,” the senator added.